mRNA-vaccines can efficiently activate both components of the immune system, i.e., T-cell and humoral responses. The essential advantage of mRNA vaccines includes fast, inexpensive, scalable and uniform production providing a large output of desirable products in vitro. Synthesis and purification processes significantly simplify the process technology of mRNA drugs with injectable purity. Thus, mRNA production via in vitro transcription is more advantageous as compared with DNA-vaccines since it is a chemical process without the use of cells. mRNA techniques make it possible to pass all the phases of vaccine development much faster in comparison with the production of vaccines based on inactivated viruses or recombinant proteins. This property is critically important when designing vaccines against viral pathogens as the main problem of disease control includes a time gap between an epidemic and vaccine development.
mRNA vaccine core enzyme is the key raw material in the production of mRNA vaccine and drugs. In this report, mRNA vaccine core enzyme includes RNA Polymerase, Capping Enzyme, 2'-O-Methyltransferase, Inorganic Pyrophosphatase, Poly (A) Polymerase, RNase Inhibitor, RNA Polymerase, Restriction Enzyme, DNase I, etc.
mR
Market Analysis and Insights: Global mRNA Vaccine Core Enzyme Market
The global mRNA Vaccine Core Enzyme market is projected to grow from US$ 2399.8 million in 2024 to US$ 2062.9 million by 2030, at a Compound Annual Growth Rate (CAGR) of -2.5% during the forecast period.
In the global market, the key players of mRNA Vaccine Core Enzyme are mainly Thermo Fisher, NEB, TriLink Bio Technologies, Merck, ect. The top three players within this industry hold about 40% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, with North America accounting for about 38% of the global market share. The product can be classified on the basis of enzyme type into capsidases, 2鈥睴-methyltransferases, inorganic pyrophosphatases, poly(A) polymerases, ribonuclease inhibitors, RNA polymerases, restriction endonucleases, deoxyribonucleases I, and other enzymes. These products are widely used by biopharmaceutical companies, academic and research institutions.
Report Covers:
This report presents an overview of global market for mRNA Vaccine Core Enzyme market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of mRNA Vaccine Core Enzyme, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for mRNA Vaccine Core Enzyme, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the mRNA Vaccine Core Enzyme revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global mRNA Vaccine Core Enzyme market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Enzyme Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for mRNA Vaccine Core Enzyme revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
Segment by Enzyme Type
Capping Enzyme
2'-O-Methyltransferase
Inorganic Pyrophosphatase
Poly (A) Polymerase
Rnase Inhibitor
RNA Polymerase
Restriction Enzyme
Dnase I
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of mRNA Vaccine Core Enzyme in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccine Core Enzyme companies鈥� competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Enzyme Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Enzyme Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Enzyme Type, by Application and by country, revenue for each segment.
Chapter 8: China by Enzyme Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Enzyme Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Enzyme Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, mRNA Vaccine Core Enzyme revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Enzyme Type
1.2.1 Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Enzyme Type, 2019 VS 2023 VS 2030
1.2.2 Capping Enzyme
1.2.3 2'-O-Methyltransferase
1.2.4 Inorganic Pyrophosphatase
1.2.5 Poly (A) Polymerase
1.2.6 Rnase Inhibitor
1.2.7 RNA Polymerase
1.2.8 Restriction Enzyme
1.2.9 Dnase I
1.2.10 Others
1.3 Market by Application
1.3.1 Global mRNA Vaccine Core Enzyme Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Vaccine Core Enzyme Market Perspective (2019-2030)
2.2 Global mRNA Vaccine Core Enzyme Growth Trends by Region
2.2.1 mRNA Vaccine Core Enzyme Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Vaccine Core Enzyme Historic Market Size by Region (2019-2024)
2.2.3 mRNA Vaccine Core Enzyme Forecasted Market Size by Region (2025-2030)
2.3 mRNA Vaccine Core Enzyme Market Dynamics
2.3.1 mRNA Vaccine Core Enzyme Industry Trends
2.3.2 mRNA Vaccine Core Enzyme Market Drivers
2.3.3 mRNA Vaccine Core Enzyme Market Challenges
2.3.4 mRNA Vaccine Core Enzyme Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue mRNA Vaccine Core Enzyme by Players
3.1.1 Global mRNA Vaccine Core Enzyme Revenue by Players (2019-2024)
3.1.2 Global mRNA Vaccine Core Enzyme Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Vaccine Core Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of mRNA Vaccine Core Enzyme, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global mRNA Vaccine Core Enzyme Market Concentration Ratio
3.4.1 Global mRNA Vaccine Core Enzyme Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine Core Enzyme Revenue in 2023
3.5 Global Key Players of mRNA Vaccine Core Enzyme Head office and Area Served
3.6 Global Key Players of mRNA Vaccine Core Enzyme, Product and Application
3.7 Global Key Players of mRNA Vaccine Core Enzyme, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Vaccine Core Enzyme Breakdown Data by Enzyme Type
4.1 Global mRNA Vaccine Core Enzyme Historic Market Size by Enzyme Type (2019-2024)
4.2 Global mRNA Vaccine Core Enzyme Forecasted Market Size by Enzyme Type (2025-2030)
5 mRNA Vaccine Core Enzyme Breakdown Data by Application
5.1 Global mRNA Vaccine Core Enzyme Historic Market Size by Application (2019-2024)
5.2 Global mRNA Vaccine Core Enzyme Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Vaccine Core Enzyme Market Size (2019-2030)
6.2 North America mRNA Vaccine Core Enzyme Market Size by Enzyme Type
6.2.1 North America mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2019-2024)
6.2.2 North America mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2025-2030)
6.2.3 North America mRNA Vaccine Core Enzyme Market Share by Enzyme Type (2019-2030)
6.3 North America mRNA Vaccine Core Enzyme Market Size by Application
6.3.1 North America mRNA Vaccine Core Enzyme Market Size by Application (2019-2024)
6.3.2 North America mRNA Vaccine Core Enzyme Market Size by Application (2025-2030)
6.3.3 North America mRNA Vaccine Core Enzyme Market Share by Application (2019-2030)
6.4 North America mRNA Vaccine Core Enzyme Market Size by Country
6.4.1 North America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America mRNA Vaccine Core Enzyme Market Size by Country (2019-2024)
6.4.3 North America mRNA Vaccine Core Enzyme Market Size by Country (2025-2030)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe mRNA Vaccine Core Enzyme Market Size (2019-2030)
7.2 Europe mRNA Vaccine Core Enzyme Market Size by Enzyme Type
7.2.1 Europe mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2019-2024)
7.2.2 Europe mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2025-2030)
7.2.3 Europe mRNA Vaccine Core Enzyme Market Share by Enzyme Type (2019-2030)
7.3 Europe mRNA Vaccine Core Enzyme Market Size by Application
7.3.1 Europe mRNA Vaccine Core Enzyme Market Size by Application (2019-2024)
7.3.2 Europe mRNA Vaccine Core Enzyme Market Size by Application (2025-2030)
7.3.3 Europe mRNA Vaccine Core Enzyme Market Share by Application (2019-2030)
7.4 Europe mRNA Vaccine Core Enzyme Market Size by Country
7.4.1 Europe mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe mRNA Vaccine Core Enzyme Market Size by Country (2019-2024)
7.4.3 Europe mRNA Vaccine Core Enzyme Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China mRNA Vaccine Core Enzyme Market Size (2019-2030)
8.2 China mRNA Vaccine Core Enzyme Market Size by Enzyme Type
8.2.1 China mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2019-2024)
8.2.2 China mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2025-2030)
8.2.3 China mRNA Vaccine Core Enzyme Market Share by Enzyme Type (2019-2030)
8.3 China mRNA Vaccine Core Enzyme Market Size by Application
8.3.1 China mRNA Vaccine Core Enzyme Market Size by Application (2019-2024)
8.3.2 China mRNA Vaccine Core Enzyme Market Size by Application (2025-2030)
8.3.3 China mRNA Vaccine Core Enzyme Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia mRNA Vaccine Core Enzyme Market Size (2019-2030)
9.2 Asia mRNA Vaccine Core Enzyme Market Size by Enzyme Type
9.2.1 Asia mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2019-2024)
9.2.2 Asia mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2025-2030)
9.2.3 Asia mRNA Vaccine Core Enzyme Market Share by Enzyme Type (2019-2030)
9.3 Asia mRNA Vaccine Core Enzyme Market Size by Application
9.3.1 Asia mRNA Vaccine Core Enzyme Market Size by Application (2019-2024)
9.3.2 Asia mRNA Vaccine Core Enzyme Market Size by Application (2025-2030)
9.3.3 Asia mRNA Vaccine Core Enzyme Market Share by Application (2019-2030)
9.4 Asia mRNA Vaccine Core Enzyme Market Size by Region
9.4.1 Asia mRNA Vaccine Core Enzyme Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia mRNA Vaccine Core Enzyme Market Size by Region (2019-2024)
9.4.3 Asia mRNA Vaccine Core Enzyme Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Enzyme Type
10.2.1 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Enzyme Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Share by Enzyme Type (2019-2030)
10.3 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Application
10.3.1 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Country
10.4.1 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America mRNA Vaccine Core Enzyme Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Details
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher mRNA Vaccine Core Enzyme Introduction
11.1.4 Thermo Fisher Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.1.5 Thermo Fisher Recent Developments
11.2 NEB
11.2.1 NEB Company Details
11.2.2 NEB Business Overview
11.2.3 NEB mRNA Vaccine Core Enzyme Introduction
11.2.4 NEB Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.2.5 NEB Recent Developments
11.3 TriLink Bio Technologies
11.3.1 TriLink Bio Technologies Company Details
11.3.2 TriLink Bio Technologies Business Overview
11.3.3 TriLink Bio Technologies mRNA Vaccine Core Enzyme Introduction
11.3.4 TriLink Bio Technologies Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.3.5 TriLink Bio Technologies Recent Developments
11.4 Merck
11.4.1 Merck Company Details
11.4.2 Merck Business Overview
11.4.3 Merck mRNA Vaccine Core Enzyme Introduction
11.4.4 Merck Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.4.5 Merck Recent Developments
11.5 Aldevron
11.5.1 Aldevron Company Details
11.5.2 Aldevron Business Overview
11.5.3 Aldevron mRNA Vaccine Core Enzyme Introduction
11.5.4 Aldevron Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.5.5 Aldevron Recent Developments
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Details
11.6.2 Qiagen N.V. Business Overview
11.6.3 Qiagen N.V. mRNA Vaccine Core Enzyme Introduction
11.6.4 Qiagen N.V. Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.6.5 Qiagen N.V. Recent Developments
11.7 Promega
11.7.1 Promega Company Details
11.7.2 Promega Business Overview
11.7.3 Promega mRNA Vaccine Core Enzyme Introduction
11.7.4 Promega Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.7.5 Promega Recent Developments
11.8 Roche CustomBiotech
11.8.1 Roche CustomBiotech Company Details
11.8.2 Roche CustomBiotech Business Overview
11.8.3 Roche CustomBiotech mRNA Vaccine Core Enzyme Introduction
11.8.4 Roche CustomBiotech Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.8.5 Roche CustomBiotech Recent Developments
11.9 Takara Bio Inc.
11.9.1 Takara Bio Inc. Company Details
11.9.2 Takara Bio Inc. Business Overview
11.9.3 Takara Bio Inc. mRNA Vaccine Core Enzyme Introduction
11.9.4 Takara Bio Inc. Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.9.5 Takara Bio Inc. Recent Developments
11.10 Novoprotein
11.10.1 Novoprotein Company Details
11.10.2 Novoprotein Business Overview
11.10.3 Novoprotein mRNA Vaccine Core Enzyme Introduction
11.10.4 Novoprotein Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.10.5 Novoprotein Recent Developments
11.11 Vazyme
11.11.1 Vazyme Company Details
11.11.2 Vazyme Business Overview
11.11.3 Vazyme mRNA Vaccine Core Enzyme Introduction
11.11.4 Vazyme Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.11.5 Vazyme Recent Developments
11.12 Hongene Biotech Corporatio
11.12.1 Hongene Biotech Corporatio Company Details
11.12.2 Hongene Biotech Corporatio Business Overview
11.12.3 Hongene Biotech Corporatio mRNA Vaccine Core Enzyme Introduction
11.12.4 Hongene Biotech Corporatio Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.12.5 Hongene Biotech Corporatio Recent Developments
11.13 Yeasen Biotechnology
11.13.1 Yeasen Biotechnology Company Details
11.13.2 Yeasen Biotechnology Business Overview
11.13.3 Yeasen Biotechnology mRNA Vaccine Core Enzyme Introduction
11.13.4 Yeasen Biotechnology Revenue in mRNA Vaccine Core Enzyme Business (2019-2024)
11.13.5 Yeasen Biotechnology Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Yeasen Biotechnology
听
听
*If Applicable.
